GenUV
Electronics · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Daejeon, Daejeon, South KoreaWebsite
www.geni-uv.comRevenue
$11.5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About GenUV
GenUV is a company that operates in the Electronics industry. It employs 50to99 people and has 10Mto25M of revenue. The company is headquartered in Daejeon, Daejeon, South Korea.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GenUV your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if GenUV is spiking on competitors!
Check if GenUV has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at GenUV
Earning: See what the market has to say on GenUV recently announced quarterly report
Funding: Get notified immidiatlly once GenUV has new funding data
Website visits: Recent activity has been detected on your website
Click to see if GenUV had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
GenUV, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when GenUV launches new products
Recommended Actions
Find VP level buyers at GenUV
Find 3 more new buyers
Company Profile Activity
Activity Insights
GenUV is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
GenUV is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about GenUV.
GenUV Tech Stack
A closer look at the technologies used by GenUV
GenUV News & Media
Genuv Announces Preclinical Data to be Released at Two Medical Conferences in June
SEOUL, South Korea--(BUSINESS WIRE)--Genuv Announces Preclinical Data to be Released at ASCO and Keystone Neurodegeneration conferences in JuneGlobal Roundup: Genuv Adds AI to Aid Discovery of Alzheimer's, ALS Therapies | BioSpace
Genuv's lead drug candidate, SNR161 has been shown to restore CNS functions in preclinical models of ALS and Alzheimer's disease. It is now being studied in a Phase I/IIa clinical trial for ALS.GENUV Unveils Preclinical Advances in the Fight Against...
GENUV presented three posters at the Keystone Virtual Symposium "Neurodegenerative Disease: Genes, Mechanisms and Therapeutics" that show its drug candidate SNR1611 demonstrated positive... (PRWeb June 10, 2021) Read the full story at https://www.prweb.com/releases/genuv_unveils_preclinical_advances_in_the_fight_against_alzheimer_s_disease_and_als/prweb17997890.htm
Read more news
Top Electronics Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GenUV
Sign Up For FreeTo access detailed company insights
GenUV is a company that operates in the Electronics industry. It employs 50to99 people and has 10Mto25M of revenue. The company is headquartered in Daejeon, Daejeon, South Korea.... Read More
